2 stellar ASX 200 growth shares analysts rate as buys

Here are a couple of exciting growth shares that have been rated as buys…

| More on:
a happy investor with a wide smile points to a graph that shows an upward trending share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Looking for growth shares to buy? Listed below are two ASX 200 growth shares that have recently been named as buys.

Here’s why they could be top options for growth investors next week:

Allkem Ltd (ASX: AKE)

The first ASX 200 growth share to consider is Allkem. It is one of the world’s leading lithium miners with a collection of world class operations and projects.

Allkem appears well-placed for growth over the next few years thanks to its production growth plans and favourable lithium prices. In respect to the former, although Allkem is already a significant producer of lithium, it recently revealed plans to increase its production three-fold by 2026.

Management notes that this will allow the company to maintain a 10% share of the global lithium market over the next decade.

Morgans is bullish on the company and has an add rating and $16.98 price target on Allkem’s shares. It commented:

AKE has been a strong performer in recent weeks but we continue to see long term valuation upside with persistent tightness in the lithium market.

We don’t think spot prices are likely to remain at current levels forever but we think there is still plenty of scope for contract prices to increase further before settling down into a long term average.

Pro Medicus Limited (ASX: PME)

Another ASX 200 growth share that could be in the buy zone is Pro Medicus. It is an industry-leading provider of software that facilitates the clinical assessment of medical images.

This software has been in demand with healthcare institutions thanks to its ability to process, transfer and store medical images and associated data efficiently. And given that speed and accuracy is fundamentally linked to both treatment success and commercial incentives, it isn’t hard to see why demand is strong and Pro Medicus keeps announcing huge long term contracts.

This has caught the eye of analysts at Bell Potter, which have put a buy rating and $55.00 price target on the company’s shares. The broker commented:

Visage 7 is the fastest, most versatile viewing software on the market and it is the key reason why Pro Medicus has been successful in winning numerous high profile hospital contracts in the US, ahead of some of the largest global names in the industry.

Furthermore, although its shares trade on higher than average multiples, the broker believes that Pro Medicus’ “prospective EPS growth is supportive of this large premium.”

Motley Fool contributor James Mickleboro has positions in Allkem Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Pro Medicus Ltd. The Motley Fool Australia has positions in and has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

3 excellent ASX growth shares that analysts are excited about

Analysts rate these growth shares very highly...

Read more »

A happy woman raises her face in celebration, indicating positive share price movement on the ASX
Growth Shares

Analysts say these ASX growth shares have huge upside potential

These growth shares could have heaps of upside...

Read more »

a graph indicating escalating results
Opinions

Where to find value in growth? Here are 2 ASX shares I’d buy in July

Both of these ASX shares could achieve good things in the future.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Growth Shares

Analysts tip big returns from these ASX growth shares

Here are two ASX growth shares analysts expect big returns from...

Read more »

happy investor, share price rise, increase, up
Growth Shares

Here’s why brokers rate these ASX growth shares as buys

Here's why these growth shares could be buys next week...

Read more »

Woman smashes dollar sign for dividend share investment
Growth Shares

2 beaten down ASX shares named as buys by experts

Here are two beaten down shares that could be buys...

Read more »

smiling man holding phone technology
Growth Shares

Analysts name 2 excellent ASX shares to buy and hold

These ASX shares could be top buy and hold options...

Read more »

The hands of three people are cupped around soil holding three small seedling plants that are grouped together in the centre of the shot with the arms of the people extending into the edges of the picture representing ASX growth shares and it being a good time to buy for future gains
Opinions

Why I think these 2 ASX shares are ideal for growth investors

This current volatile period could be a great time to go hunting for compelling businesses with strong growth potential.

Read more »